4.02
  Price0.50%   +0.0200
(After Hours: 4.02 0 +0.00%)
Apr-22-21 10:35AM 22nd Century Group to Host Webcast to Discuss First Quarter 2021 ResultsGlobeNewswire
Apr-21-21 10:35AM 22nd Century Group Issues Annual Letter to ShareholdersGlobeNewswire
Apr-20-21 04:00AM 22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.GlobeNewswire
Apr-15-21 05:56AM 22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action PlanGlobeNewswire
Apr-08-21 10:06AM 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products CommitteeGlobeNewswire
Apr-06-21 07:12AM 3 Best Emerging Marijuana Stocks to Buy in AprilMotley Fool
Apr-01-21 10:06AM Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd CenturyGlobeNewswire
Mar-23-21 09:30AM 22nd Century Group (NYSEMKT:XXII) Is In A Good Position To Deliver On Growth PlansSimply Wall St.
Mar-19-21 01:00AM Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco IndustryGlobeNewswire
08:30AM Do Options Traders Know Something About 22nd Century (XXII) Stock We Don't?Zacks
Mar-12-21 01:55AM Why 22nd Century Group Stock Just Lit UpMotley Fool
10:00AM 22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding WarrantsGlobeNewswire
Mar-11-21 06:30AM 22nd Century Group (XXII) Q4 2020 Earnings Call TranscriptMotley Fool
07:00AM 22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020GlobeNewswire
Mar-05-21 09:15AM 22nd Century Group to Participate in Investor Conferences in March 2021GlobeNewswire
Mar-04-21 12:30PM Will 22nd Century Group (XXII) Report Negative Earnings Next Week? What You Should KnowZacks
09:15AM 22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding WarrantsGlobeNewswire
Mar-03-21 09:00AM 22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual PropertyGlobeNewswire
Feb-25-21 07:30AM 22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 ResultsGlobeNewswire
Feb-24-21 10:00AM 22nd Century Group Provides Business Update Letter from CEOGlobeNewswire
Feb-10-21 10:00AM 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable TraitsGlobeNewswire
Jan-28-21 10:00AM 22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville DistrictGlobeNewswire
Jan-26-21 12:00PM The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in CigarettesGlobeNewswire
Jan-19-21 07:30AM Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century GroupGlobeNewswire
Jan-12-21 11:00AM 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content CigarettesGlobeNewswire
Jan-11-21 12:00PM 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content CigarettesGlobeNewswire
Dec-23-20 04:49AM Did Business Growth Power 22nd Century Group's (NYSEMKT:XXII) Share Price Gain of 116%?Simply Wall St.
Dec-17-20 10:10AM 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable CannabinoidsGlobeNewswire
Dec-15-20 08:54AM Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock?Zacks
Dec-14-20 08:49AM Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock?Zacks
Dec-08-20 10:00AM 22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported ResearchGlobeNewswire
Dec-04-20 10:00AM 22nd Century Group to Present at 13th Annual LD Micro Main Event ConferenceGlobeNewswire
Nov-29-20 08:37AM Is 22nd Century Group, Inc (XXII) A Good Stock To Buy?Insider Monkey
Nov-24-20 11:00AM 22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy ArticleGlobeNewswire
Nov-18-20 10:00AM 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis ConferenceGlobeNewswire
Nov-16-20 09:45AM 22nd Century Group to Present at the Virtual Fall Investor Summit on November 17GlobeNewswire
Nov-12-20 08:36AM Implied Volatility Surging for 22nd Century (XXII) Stock OptionsZacks
Nov-05-20 10:05AM 22nd Century Group (XXII) Reports Q3 Loss, Tops Revenue EstimatesZacks
07:00AM 22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020GlobeNewswire
Oct-29-20 12:35PM 22nd Century Group (XXII) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks
Oct-22-20 10:00AM 22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&AGlobeNewswire
Oct-19-20 10:00AM 22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy ConferenceGlobeNewswire
Oct-15-20 08:58AM 22nd Century (XXII) in Focus: Stock Moves 9.9% HigherZacks
Oct-14-20 01:00AM 22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco PlantsGlobeNewswire
Sep-24-20 04:05AM 22nd Century Group Provides Strategy Update Letter from CEOGlobeNewswire
Sep-23-20 12:26PM Health Check: How Prudently Does 22nd Century Group (NYSEMKT:XXII) Use Debt?Simply Wall St.
Sep-17-20 04:05AM 22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of DirectorsGlobeNewswire
Aug-31-20 06:05AM LD Micro: 360 Companies Set to Present this WeekACCESSWIRE
Aug-27-20 11:30AM 22nd Century Group to Present at the LD Micro 500 Virtual ConferenceGlobeNewswire
Aug-06-20 07:00AM 22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020GlobeNewswire
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Cap:    |  Volume (24h):